Neri A - Search Results

1

A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.

Morelli E, Fulciniti M, Samur MK, Ribeiro CF, Wert-Lamas L, Henninger JE, Gullà A, Aktas-Samur A, Todoerti K, Talluri S, Park WD, Federico C, Scionti F, Amodio N, Bianchi G, Johnstone M, Liu N, Gramegna D, Maisano D, Russo NA, Lin C, Tai YT, Neri A, Chauhan D, Hideshima T, Shammas MA, Tassone P, Gryaznov S, Young RA, Anderson KC, Novina CD, Loda M, Munshi NC. Morelli E, et al. Among authors: neri a. Blood. 2023 Jan 26;141(4):391-405. doi: 10.1182/blood.2022016892. Blood. 2023. PMID: 36126301 Free PMC article.

2

Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.

Verdelli D, Mattioli M, Fabris S, Nobili L, Intini D, Guerneri S, Todoerti K, Zanella A, Deliliers GL, Lombardi L, Neri A. Verdelli D, et al. Among authors: neri a. Haematologica. 2005 Nov;90(11):1541-8. Haematologica. 2005. PMID: 16266902

3

Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.

Fabris S, Todoerti K, Mosca L, Agnelli L, Intini D, Lionetti M, Guerneri S, Lambertenghi-Deliliers G, Bertoni F, Neri A. Fabris S, et al. Among authors: neri a. Genes Chromosomes Cancer. 2007 Dec;46(12):1109-18. doi: 10.1002/gcc.20494. Genes Chromosomes Cancer. 2007. PMID: 17823926

4

Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.

Verdelli D, Nobili L, Todoerti K, Intini D, Cosenza M, Civallero M, Bertacchini J, Deliliers GL, Sacchi S, Lombardi L, Neri A. Verdelli D, et al. Among authors: neri a. Hematol Oncol. 2009 Mar;27(1):23-30. doi: 10.1002/hon.875. Hematol Oncol. 2009. PMID: 18759374

5

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

Lionetti M, Agnelli L, Mosca L, Fabris S, Andronache A, Todoerti K, Ronchetti D, Deliliers GL, Neri A. Lionetti M, et al. Among authors: neri a. Genes Chromosomes Cancer. 2009 Jun;48(6):521-31. doi: 10.1002/gcc.20660. Genes Chromosomes Cancer. 2009. PMID: 19306352

6

Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b.

Todoerti K, Barbui V, Pedrini O, Lionetti M, Fossati G, Mascagni P, Rambaldi A, Neri A, Introna M, Lombardi L, Golay J. Todoerti K, et al. Among authors: neri a. Haematologica. 2010 Feb;95(2):260-9. doi: 10.3324/haematol.2009.012088. Epub 2009 Aug 27. Haematologica. 2010. PMID: 19713220 Free PMC article.

7

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.

Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, Fabris S, Sales G, Deliliers GL, Bicciato S, Lombardi L, Bortoluzzi S, Neri A. Lionetti M, et al. Among authors: neri a. Blood. 2009 Dec 10;114(25):e20-6. doi: 10.1182/blood-2009-08-237495. Blood. 2009. PMID: 19846888 Free article.

8

The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma.

Agnelli L, Forcato M, Ferrari F, Tuana G, Todoerti K, Walker BA, Morgan GJ, Lombardi L, Bicciato S, Neri A. Agnelli L, et al. Among authors: neri a. Clin Cancer Res. 2011 Dec 1;17(23):7402-12. doi: 10.1158/1078-0432.CCR-11-0596. Epub 2011 Sep 2. Clin Cancer Res. 2011. PMID: 21890453

9

Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations.

Agnelli L, Storti P, Todoerti K, Sammarelli G, Dalla Palma B, Bolzoni M, Rocci A, Piazza F, Semenzato G, Palumbo A, Neri A, Giuliani N. Agnelli L, et al. Among authors: neri a. Am J Hematol. 2011 Dec;86(12):E64-6. doi: 10.1002/ajh.22164. Epub 2011 Sep 22. Am J Hematol. 2011. PMID: 21953534 Free article.

10

MicroRNAs in the pathobiology of multiple myeloma.

Lionetti M, Agnelli L, Lombardi L, Tassone P, Neri A. Lionetti M, et al. Among authors: neri a. Curr Cancer Drug Targets. 2012 Sep;12(7):823-37. doi: 10.2174/156800912802429274. Curr Cancer Drug Targets. 2012. PMID: 22671930 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,150 results

Search Page